Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Frusemide: a safe diuretic during lithium therapy?

D Saffer, A Coppen

    Journal of Affective Disorders
    |November 1, 1983
    PubMed
    Summary

    Frusemide, a diuretic, was studied in patients on lithium therapy for affective disorders. The 12-week study found no significant changes in plasma lithium levels, indicating frusemide is safe for these patients.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    PERIPHERAL SEROTONERGIC AND ADRENERGIC RESPONSES IN DEPRESSION.

    Acta psychiatrica Scandinavica·2017
    Same author

    TRACE AMINE DEFICIT IN DEPRESSIVE ILLNESS: THE PHENYLALANINE CONNEXION.

    Acta psychiatrica Scandinavica·2017
    Same author

    Chairman's introduction.

    Journal of psychopharmacology (Oxford, England)·2012
    Same author

    Chairman's summary.

    Journal of psychopharmacology (Oxford, England)·2012
    Same author

    Optic neuritis in an urban black African community.

    Eye (London, England)·2002
    Same author

    50 years of lithium treatment of mood disorders.

    Bipolar disorders·2001

    Area of Science:

    • Pharmacology
    • Nephrology
    • Psychiatry

    Background:

    • Lithium is a common prophylactic treatment for affective disorders.
    • Diuretics are often prescribed for hypertension, a common comorbidity.
    • Potential interactions between lithium and diuretics require investigation.

    Purpose of the Study:

    • To evaluate the effect of frusemide on plasma lithium concentrations.
    • To determine the safety of co-administering frusemide and lithium.
    • To assess the impact on patients with affective disorders on prophylactic lithium.

    Main Methods:

    • Therapeutic doses of frusemide administered to patients receiving prophylactic lithium.
    • Plasma lithium concentrations monitored over a 12-week period.
    • Analysis of changes in lithium levels and potential adverse effects.

    Main Results:

    • No significant effect of frusemide on plasma lithium concentration was observed.
    • Lithium levels remained stable throughout the 12-week study duration.
    • No adverse events related to the co-administration were reported.

    Conclusions:

    • Frusemide can be safely administered to patients undergoing lithium therapy.
    • The diuretic does not appear to interfere with lithium's efficacy or safety profile.
    • This finding supports the use of frusemide in hypertensive patients on lithium treatment.

    Related Experiment Videos